nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzatropine—CYP2D6—breast cancer	0.203	1	CbGaD
Benzatropine—Cloperastine—Raloxifene—breast cancer	0.127	0.249	CrCrCtD
Benzatropine—Benzphetamine—Toremifene—breast cancer	0.0616	0.121	CrCrCtD
Benzatropine—Orphenadrine—Toremifene—breast cancer	0.0616	0.121	CrCrCtD
Benzatropine—Benzyl Benzoate—Toremifene—breast cancer	0.0571	0.112	CrCrCtD
Benzatropine—Diphenhydramine—Toremifene—breast cancer	0.0547	0.107	CrCrCtD
Benzatropine—Benzphetamine—Tamoxifen—breast cancer	0.0387	0.0759	CrCrCtD
Benzatropine—Orphenadrine—Tamoxifen—breast cancer	0.0387	0.0759	CrCrCtD
Benzatropine—Benzyl Benzoate—Tamoxifen—breast cancer	0.0358	0.0703	CrCrCtD
Benzatropine—Diphenhydramine—Tamoxifen—breast cancer	0.0343	0.0674	CrCrCtD
Benzatropine—CYP2C19—Lapatinib—breast cancer	0.0331	0.279	CbGbCtD
Benzatropine—CYP2D6—Idarubicin—breast cancer	0.0286	0.241	CbGbCtD
Benzatropine—CYP2C19—Tamoxifen—breast cancer	0.0166	0.14	CbGbCtD
Benzatropine—CYP2D6—Vinorelbine—breast cancer	0.014	0.118	CbGbCtD
Benzatropine—CYP2D6—Tamoxifen—breast cancer	0.0126	0.106	CbGbCtD
Benzatropine—CYP2D6—Vinblastine—breast cancer	0.00861	0.0725	CbGbCtD
Benzatropine—CYP2D6—Doxorubicin—breast cancer	0.00529	0.0445	CbGbCtD
Benzatropine—Hypoaesthesia—Vinorelbine—breast cancer	0.000374	0.00344	CcSEcCtD
Benzatropine—Cerebrovascular accident—Paclitaxel—breast cancer	0.000373	0.00343	CcSEcCtD
Benzatropine—Rash—Fulvestrant—breast cancer	0.000372	0.00343	CcSEcCtD
Benzatropine—Dermatitis—Fulvestrant—breast cancer	0.000372	0.00343	CcSEcCtD
Benzatropine—Dysphagia—Fluorouracil—breast cancer	0.000371	0.00342	CcSEcCtD
Benzatropine—Vomiting—Toremifene—breast cancer	0.000371	0.00342	CcSEcCtD
Benzatropine—Rash—Toremifene—breast cancer	0.000368	0.00339	CcSEcCtD
Benzatropine—Dermatitis—Toremifene—breast cancer	0.000367	0.00338	CcSEcCtD
Benzatropine—Body temperature increased—Anastrozole—breast cancer	0.00036	0.00332	CcSEcCtD
Benzatropine—Body temperature increased—Letrozole—breast cancer	0.00036	0.00332	CcSEcCtD
Benzatropine—Trimethaphan—BCHE—breast cancer	0.00036	0.167	CrCbGaD
Benzatropine—Tension—Goserelin—breast cancer	0.000358	0.0033	CcSEcCtD
Benzatropine—Hypersensitivity—Ixabepilone—breast cancer	0.000357	0.00329	CcSEcCtD
Benzatropine—Nervousness—Goserelin—breast cancer	0.000355	0.00327	CcSEcCtD
Benzatropine—Confusional state—Chlorambucil—breast cancer	0.000353	0.00326	CcSEcCtD
Benzatropine—Nausea—Fulvestrant—breast cancer	0.000351	0.00323	CcSEcCtD
Benzatropine—Nausea—Toremifene—breast cancer	0.000346	0.00319	CcSEcCtD
Benzatropine—Vision blurred—Goserelin—breast cancer	0.000344	0.00317	CcSEcCtD
Benzatropine—Body temperature increased—Raloxifene—breast cancer	0.000342	0.00315	CcSEcCtD
Benzatropine—Body temperature increased—Idarubicin—breast cancer	0.000342	0.00315	CcSEcCtD
Benzatropine—Hypersensitivity—Anastrozole—breast cancer	0.000336	0.00309	CcSEcCtD
Benzatropine—Vomiting—Exemestane—breast cancer	0.000326	0.00301	CcSEcCtD
Benzatropine—Rash—Exemestane—breast cancer	0.000323	0.00298	CcSEcCtD
Benzatropine—Dermatitis—Exemestane—breast cancer	0.000323	0.00298	CcSEcCtD
Benzatropine—Hypersensitivity—Idarubicin—breast cancer	0.000319	0.00294	CcSEcCtD
Benzatropine—Dry mouth—Tamoxifen—breast cancer	0.000318	0.00293	CcSEcCtD
Benzatropine—Dysphagia—Paclitaxel—breast cancer	0.000316	0.00291	CcSEcCtD
Benzatropine—Vomiting—Ixabepilone—breast cancer	0.000308	0.00284	CcSEcCtD
Benzatropine—Tension—Thiotepa—breast cancer	0.000306	0.00282	CcSEcCtD
Benzatropine—Cerebrovascular accident—Capecitabine—breast cancer	0.000306	0.00282	CcSEcCtD
Benzatropine—Rash—Ixabepilone—breast cancer	0.000305	0.00281	CcSEcCtD
Benzatropine—Dermatitis—Ixabepilone—breast cancer	0.000305	0.00281	CcSEcCtD
Benzatropine—Nausea—Exemestane—breast cancer	0.000305	0.00281	CcSEcCtD
Benzatropine—Decreased appetite—Chlorambucil—breast cancer	0.000305	0.00281	CcSEcCtD
Benzatropine—Dry mouth—Goserelin—breast cancer	0.000304	0.0028	CcSEcCtD
Benzatropine—Nervousness—Thiotepa—breast cancer	0.000303	0.00279	CcSEcCtD
Benzatropine—Confusional state—Goserelin—breast cancer	0.0003	0.00277	CcSEcCtD
Benzatropine—Tachycardia—Melphalan—breast cancer	0.000298	0.00275	CcSEcCtD
Benzatropine—Hypoaesthesia—Fluorouracil—breast cancer	0.000295	0.00272	CcSEcCtD
Benzatropine—Dysuria—Paclitaxel—breast cancer	0.000295	0.00272	CcSEcCtD
Benzatropine—Vision blurred—Thiotepa—breast cancer	0.000294	0.00271	CcSEcCtD
Benzatropine—Tachycardia—Goserelin—breast cancer	0.000291	0.00268	CcSEcCtD
Benzatropine—Vomiting—Letrozole—breast cancer	0.00029	0.00267	CcSEcCtD
Benzatropine—Vomiting—Anastrozole—breast cancer	0.00029	0.00267	CcSEcCtD
Benzatropine—Feeling abnormal—Chlorambucil—breast cancer	0.000289	0.00266	CcSEcCtD
Benzatropine—Nausea—Ixabepilone—breast cancer	0.000288	0.00265	CcSEcCtD
Benzatropine—Rash—Anastrozole—breast cancer	0.000287	0.00265	CcSEcCtD
Benzatropine—Rash—Letrozole—breast cancer	0.000287	0.00265	CcSEcCtD
Benzatropine—Dermatitis—Anastrozole—breast cancer	0.000287	0.00265	CcSEcCtD
Benzatropine—Dermatitis—Letrozole—breast cancer	0.000287	0.00265	CcSEcCtD
Benzatropine—Urinary retention—Capecitabine—breast cancer	0.000285	0.00263	CcSEcCtD
Benzatropine—Decreased appetite—Vinblastine—breast cancer	0.000279	0.00257	CcSEcCtD
Benzatropine—Body temperature increased—Chlorambucil—breast cancer	0.000277	0.00255	CcSEcCtD
Benzatropine—Vomiting—Raloxifene—breast cancer	0.000275	0.00253	CcSEcCtD
Benzatropine—Vomiting—Idarubicin—breast cancer	0.000275	0.00253	CcSEcCtD
Benzatropine—Constipation—Vinblastine—breast cancer	0.000275	0.00253	CcSEcCtD
Benzatropine—Rash—Raloxifene—breast cancer	0.000273	0.00251	CcSEcCtD
Benzatropine—Rash—Idarubicin—breast cancer	0.000273	0.00251	CcSEcCtD
Benzatropine—Dermatitis—Idarubicin—breast cancer	0.000273	0.00251	CcSEcCtD
Benzatropine—Dermatitis—Raloxifene—breast cancer	0.000273	0.00251	CcSEcCtD
Benzatropine—Decreased appetite—Tamoxifen—breast cancer	0.000271	0.0025	CcSEcCtD
Benzatropine—Nausea—Letrozole—breast cancer	0.000271	0.0025	CcSEcCtD
Benzatropine—Nausea—Anastrozole—breast cancer	0.000271	0.0025	CcSEcCtD
Benzatropine—Dysphagia—Docetaxel—breast cancer	0.000268	0.00247	CcSEcCtD
Benzatropine—Constipation—Tamoxifen—breast cancer	0.000267	0.00246	CcSEcCtD
Benzatropine—Decreased appetite—Melphalan—breast cancer	0.000265	0.00245	CcSEcCtD
Benzatropine—Feeling abnormal—Vinblastine—breast cancer	0.000265	0.00244	CcSEcCtD
Benzatropine—Tachycardia—Vinorelbine—breast cancer	0.00026	0.0024	CcSEcCtD
Benzatropine—Dysphagia—Capecitabine—breast cancer	0.000259	0.00239	CcSEcCtD
Benzatropine—Decreased appetite—Goserelin—breast cancer	0.000259	0.00239	CcSEcCtD
Benzatropine—Hypersensitivity—Chlorambucil—breast cancer	0.000258	0.00238	CcSEcCtD
Benzatropine—Nausea—Idarubicin—breast cancer	0.000257	0.00237	CcSEcCtD
Benzatropine—Nausea—Raloxifene—breast cancer	0.000257	0.00237	CcSEcCtD
Benzatropine—Confusional state—Thiotepa—breast cancer	0.000257	0.00237	CcSEcCtD
Benzatropine—Constipation—Goserelin—breast cancer	0.000255	0.00235	CcSEcCtD
Benzatropine—Vision blurred—Mitoxantrone—breast cancer	0.000254	0.00234	CcSEcCtD
Benzatropine—Hypoaesthesia—Paclitaxel—breast cancer	0.000251	0.00232	CcSEcCtD
Benzatropine—Tachycardia—Thiotepa—breast cancer	0.000249	0.00229	CcSEcCtD
Benzatropine—Feeling abnormal—Goserelin—breast cancer	0.000246	0.00226	CcSEcCtD
Benzatropine—Vision blurred—Fluorouracil—breast cancer	0.000243	0.00224	CcSEcCtD
Benzatropine—Dysuria—Capecitabine—breast cancer	0.000242	0.00223	CcSEcCtD
Benzatropine—Hypersensitivity—Vinblastine—breast cancer	0.000237	0.00218	CcSEcCtD
Benzatropine—Body temperature increased—Goserelin—breast cancer	0.000236	0.00217	CcSEcCtD
Benzatropine—Decreased appetite—Vinorelbine—breast cancer	0.000232	0.00214	CcSEcCtD
Benzatropine—Hypersensitivity—Tamoxifen—breast cancer	0.00023	0.00212	CcSEcCtD
Benzatropine—Constipation—Vinorelbine—breast cancer	0.000228	0.0021	CcSEcCtD
Benzatropine—Cerebrovascular accident—Methotrexate—breast cancer	0.000228	0.0021	CcSEcCtD
Benzatropine—Hypersensitivity—Melphalan—breast cancer	0.000225	0.00207	CcSEcCtD
Benzatropine—Vomiting—Chlorambucil—breast cancer	0.000223	0.00205	CcSEcCtD
Benzatropine—Confusional state—Mitoxantrone—breast cancer	0.000222	0.00204	CcSEcCtD
Benzatropine—Confusional state—Irinotecan—breast cancer	0.000222	0.00204	CcSEcCtD
Benzatropine—Decreased appetite—Thiotepa—breast cancer	0.000222	0.00204	CcSEcCtD
Benzatropine—Feeling abnormal—Vinorelbine—breast cancer	0.00022	0.00203	CcSEcCtD
Benzatropine—Hypersensitivity—Goserelin—breast cancer	0.000219	0.00202	CcSEcCtD
Benzatropine—Constipation—Thiotepa—breast cancer	0.000218	0.00201	CcSEcCtD
Benzatropine—Tension—Paclitaxel—breast cancer	0.000216	0.00199	CcSEcCtD
Benzatropine—Tachycardia—Mitoxantrone—breast cancer	0.000215	0.00198	CcSEcCtD
Benzatropine—Nervousness—Paclitaxel—breast cancer	0.000214	0.00197	CcSEcCtD
Benzatropine—Hypoaesthesia—Docetaxel—breast cancer	0.000213	0.00196	CcSEcCtD
Benzatropine—Cerebrovascular accident—Epirubicin—breast cancer	0.000213	0.00196	CcSEcCtD
Benzatropine—Confusional state—Fluorouracil—breast cancer	0.000213	0.00196	CcSEcCtD
Benzatropine—Body temperature increased—Vinorelbine—breast cancer	0.000211	0.00194	CcSEcCtD
Benzatropine—Feeling abnormal—Thiotepa—breast cancer	0.00021	0.00194	CcSEcCtD
Benzatropine—Nausea—Chlorambucil—breast cancer	0.000208	0.00192	CcSEcCtD
Benzatropine—Vision blurred—Paclitaxel—breast cancer	0.000207	0.00191	CcSEcCtD
Benzatropine—Hypoaesthesia—Capecitabine—breast cancer	0.000206	0.0019	CcSEcCtD
Benzatropine—Tachycardia—Fluorouracil—breast cancer	0.000206	0.0019	CcSEcCtD
Benzatropine—Vomiting—Vinblastine—breast cancer	0.000204	0.00188	CcSEcCtD
Benzatropine—Body temperature increased—Thiotepa—breast cancer	0.000201	0.00186	CcSEcCtD
Benzatropine—Orphenadrine—SCN10A—breast cancer	0.000201	0.0937	CrCbGaD
Benzatropine—Reboxetine—CYP2D6—breast cancer	0.000201	0.0935	CrCbGaD
Benzatropine—Vomiting—Tamoxifen—breast cancer	0.000198	0.00183	CcSEcCtD
Benzatropine—Trospium—CYP2D6—breast cancer	0.000197	0.0918	CrCbGaD
Benzatropine—Cerebrovascular accident—Doxorubicin—breast cancer	0.000197	0.00182	CcSEcCtD
Benzatropine—Rash—Tamoxifen—breast cancer	0.000197	0.00181	CcSEcCtD
Benzatropine—Hypersensitivity—Vinorelbine—breast cancer	0.000197	0.00181	CcSEcCtD
Benzatropine—Dermatitis—Tamoxifen—breast cancer	0.000196	0.00181	CcSEcCtD
Benzatropine—Vomiting—Melphalan—breast cancer	0.000194	0.00179	CcSEcCtD
Benzatropine—Rash—Melphalan—breast cancer	0.000193	0.00177	CcSEcCtD
Benzatropine—Dermatitis—Melphalan—breast cancer	0.000192	0.00177	CcSEcCtD
Benzatropine—Decreased appetite—Irinotecan—breast cancer	0.000191	0.00176	CcSEcCtD
Benzatropine—Decreased appetite—Mitoxantrone—breast cancer	0.000191	0.00176	CcSEcCtD
Benzatropine—Nausea—Vinblastine—breast cancer	0.000191	0.00176	CcSEcCtD
Benzatropine—Vomiting—Goserelin—breast cancer	0.000189	0.00175	CcSEcCtD
Benzatropine—Constipation—Irinotecan—breast cancer	0.000188	0.00173	CcSEcCtD
Benzatropine—Constipation—Mitoxantrone—breast cancer	0.000188	0.00173	CcSEcCtD
Benzatropine—Rash—Goserelin—breast cancer	0.000188	0.00173	CcSEcCtD
Benzatropine—Hypersensitivity—Thiotepa—breast cancer	0.000188	0.00173	CcSEcCtD
Benzatropine—Dermatitis—Goserelin—breast cancer	0.000188	0.00173	CcSEcCtD
Benzatropine—Decreased appetite—Gemcitabine—breast cancer	0.000186	0.00172	CcSEcCtD
Benzatropine—Nausea—Tamoxifen—breast cancer	0.000185	0.00171	CcSEcCtD
Benzatropine—Constipation—Gemcitabine—breast cancer	0.000183	0.00169	CcSEcCtD
Benzatropine—Decreased appetite—Fluorouracil—breast cancer	0.000183	0.00169	CcSEcCtD
Benzatropine—Dry mouth—Paclitaxel—breast cancer	0.000183	0.00169	CcSEcCtD
Benzatropine—Nausea—Melphalan—breast cancer	0.000181	0.00167	CcSEcCtD
Benzatropine—Feeling abnormal—Irinotecan—breast cancer	0.000181	0.00167	CcSEcCtD
Benzatropine—Feeling abnormal—Mitoxantrone—breast cancer	0.000181	0.00167	CcSEcCtD
Benzatropine—Confusional state—Paclitaxel—breast cancer	0.000181	0.00167	CcSEcCtD
Benzatropine—Dysphagia—Epirubicin—breast cancer	0.00018	0.00166	CcSEcCtD
Benzatropine—Dysuria—Methotrexate—breast cancer	0.00018	0.00166	CcSEcCtD
Benzatropine—Nausea—Goserelin—breast cancer	0.000177	0.00163	CcSEcCtD
Benzatropine—Feeling abnormal—Gemcitabine—breast cancer	0.000177	0.00163	CcSEcCtD
Benzatropine—Tachycardia—Paclitaxel—breast cancer	0.000175	0.00161	CcSEcCtD
Benzatropine—Body temperature increased—Irinotecan—breast cancer	0.000174	0.0016	CcSEcCtD
Benzatropine—Body temperature increased—Mitoxantrone—breast cancer	0.000174	0.0016	CcSEcCtD
Benzatropine—Feeling abnormal—Fluorouracil—breast cancer	0.000174	0.0016	CcSEcCtD
Benzatropine—Reboxetine—CYP3A4—breast cancer	0.000172	0.0802	CrCbGaD
Benzatropine—Vision blurred—Capecitabine—breast cancer	0.00017	0.00157	CcSEcCtD
Benzatropine—Vomiting—Vinorelbine—breast cancer	0.00017	0.00156	CcSEcCtD
Benzatropine—Body temperature increased—Gemcitabine—breast cancer	0.000169	0.00156	CcSEcCtD
Benzatropine—Dysuria—Epirubicin—breast cancer	0.000169	0.00155	CcSEcCtD
Benzatropine—Rash—Vinorelbine—breast cancer	0.000168	0.00155	CcSEcCtD
Benzatropine—Dermatitis—Vinorelbine—breast cancer	0.000168	0.00155	CcSEcCtD
Benzatropine—Dysphagia—Doxorubicin—breast cancer	0.000167	0.00154	CcSEcCtD
Benzatropine—Body temperature increased—Fluorouracil—breast cancer	0.000167	0.00154	CcSEcCtD
Benzatropine—Hypersensitivity—Irinotecan—breast cancer	0.000162	0.00149	CcSEcCtD
Benzatropine—Hypersensitivity—Mitoxantrone—breast cancer	0.000162	0.00149	CcSEcCtD
Benzatropine—Vomiting—Thiotepa—breast cancer	0.000162	0.00149	CcSEcCtD
Benzatropine—Rash—Thiotepa—breast cancer	0.000161	0.00148	CcSEcCtD
Benzatropine—Dermatitis—Thiotepa—breast cancer	0.000161	0.00148	CcSEcCtD
Benzatropine—Nausea—Vinorelbine—breast cancer	0.000158	0.00146	CcSEcCtD
Benzatropine—Dysuria—Doxorubicin—breast cancer	0.000156	0.00144	CcSEcCtD
Benzatropine—Decreased appetite—Paclitaxel—breast cancer	0.000156	0.00144	CcSEcCtD
Benzatropine—Hypersensitivity—Fluorouracil—breast cancer	0.000155	0.00143	CcSEcCtD
Benzatropine—Dry mouth—Docetaxel—breast cancer	0.000155	0.00143	CcSEcCtD
Benzatropine—Constipation—Paclitaxel—breast cancer	0.000153	0.00141	CcSEcCtD
Benzatropine—Confusional state—Docetaxel—breast cancer	0.000153	0.00141	CcSEcCtD
Benzatropine—Nausea—Thiotepa—breast cancer	0.000151	0.00139	CcSEcCtD
Benzatropine—Dry mouth—Capecitabine—breast cancer	0.00015	0.00138	CcSEcCtD
Benzatropine—Confusional state—Capecitabine—breast cancer	0.000149	0.00137	CcSEcCtD
Benzatropine—Tachycardia—Docetaxel—breast cancer	0.000148	0.00137	CcSEcCtD
Benzatropine—Feeling abnormal—Paclitaxel—breast cancer	0.000148	0.00136	CcSEcCtD
Benzatropine—Tachycardia—Capecitabine—breast cancer	0.000144	0.00132	CcSEcCtD
Benzatropine—Hypoaesthesia—Epirubicin—breast cancer	0.000144	0.00132	CcSEcCtD
Benzatropine—Reboxetine—ABCB1—breast cancer	0.000144	0.0668	CrCbGaD
Benzatropine—Body temperature increased—Paclitaxel—breast cancer	0.000142	0.00131	CcSEcCtD
Benzatropine—Vomiting—Irinotecan—breast cancer	0.00014	0.00129	CcSEcCtD
Benzatropine—Vomiting—Mitoxantrone—breast cancer	0.00014	0.00129	CcSEcCtD
Benzatropine—Rash—Mitoxantrone—breast cancer	0.000139	0.00128	CcSEcCtD
Benzatropine—Rash—Irinotecan—breast cancer	0.000139	0.00128	CcSEcCtD
Benzatropine—Dermatitis—Irinotecan—breast cancer	0.000139	0.00128	CcSEcCtD
Benzatropine—Dermatitis—Mitoxantrone—breast cancer	0.000139	0.00128	CcSEcCtD
Benzatropine—Vomiting—Gemcitabine—breast cancer	0.000136	0.00126	CcSEcCtD
Benzatropine—Rash—Gemcitabine—breast cancer	0.000135	0.00125	CcSEcCtD
Benzatropine—Dermatitis—Gemcitabine—breast cancer	0.000135	0.00124	CcSEcCtD
Benzatropine—Vomiting—Fluorouracil—breast cancer	0.000134	0.00124	CcSEcCtD
Benzatropine—Hypoaesthesia—Doxorubicin—breast cancer	0.000133	0.00123	CcSEcCtD
Benzatropine—Rash—Fluorouracil—breast cancer	0.000133	0.00122	CcSEcCtD
Benzatropine—Dermatitis—Fluorouracil—breast cancer	0.000133	0.00122	CcSEcCtD
Benzatropine—Decreased appetite—Docetaxel—breast cancer	0.000132	0.00122	CcSEcCtD
Benzatropine—Hypersensitivity—Paclitaxel—breast cancer	0.000132	0.00122	CcSEcCtD
Benzatropine—Nausea—Mitoxantrone—breast cancer	0.000131	0.0012	CcSEcCtD
Benzatropine—Nausea—Irinotecan—breast cancer	0.000131	0.0012	CcSEcCtD
Benzatropine—Constipation—Docetaxel—breast cancer	0.00013	0.0012	CcSEcCtD
Benzatropine—Decreased appetite—Capecitabine—breast cancer	0.000128	0.00118	CcSEcCtD
Benzatropine—Nausea—Gemcitabine—breast cancer	0.000127	0.00117	CcSEcCtD
Benzatropine—Vision blurred—Methotrexate—breast cancer	0.000127	0.00117	CcSEcCtD
Benzatropine—Constipation—Capecitabine—breast cancer	0.000126	0.00116	CcSEcCtD
Benzatropine—Feeling abnormal—Docetaxel—breast cancer	0.000125	0.00116	CcSEcCtD
Benzatropine—Nausea—Fluorouracil—breast cancer	0.000125	0.00115	CcSEcCtD
Benzatropine—Tension—Epirubicin—breast cancer	0.000123	0.00114	CcSEcCtD
Benzatropine—Cinnarizine—CYP1A1—breast cancer	0.000122	0.0569	CrCbGaD
Benzatropine—Nervousness—Epirubicin—breast cancer	0.000122	0.00113	CcSEcCtD
Benzatropine—Feeling abnormal—Capecitabine—breast cancer	0.000121	0.00112	CcSEcCtD
Benzatropine—Body temperature increased—Docetaxel—breast cancer	0.00012	0.00111	CcSEcCtD
Benzatropine—Vision blurred—Epirubicin—breast cancer	0.000118	0.00109	CcSEcCtD
Benzatropine—Body temperature increased—Capecitabine—breast cancer	0.000116	0.00107	CcSEcCtD
Benzatropine—Tension—Doxorubicin—breast cancer	0.000114	0.00105	CcSEcCtD
Benzatropine—Vomiting—Paclitaxel—breast cancer	0.000114	0.00105	CcSEcCtD
Benzatropine—Rash—Paclitaxel—breast cancer	0.000113	0.00104	CcSEcCtD
Benzatropine—Dermatitis—Paclitaxel—breast cancer	0.000113	0.00104	CcSEcCtD
Benzatropine—Nervousness—Doxorubicin—breast cancer	0.000113	0.00104	CcSEcCtD
Benzatropine—Hypersensitivity—Docetaxel—breast cancer	0.000112	0.00103	CcSEcCtD
Benzatropine—Confusional state—Methotrexate—breast cancer	0.000111	0.00102	CcSEcCtD
Benzatropine—Vision blurred—Doxorubicin—breast cancer	0.00011	0.00101	CcSEcCtD
Benzatropine—Hypersensitivity—Capecitabine—breast cancer	0.000109	0.001	CcSEcCtD
Benzatropine—Nausea—Paclitaxel—breast cancer	0.000107	0.000982	CcSEcCtD
Benzatropine—Dry mouth—Epirubicin—breast cancer	0.000105	0.000965	CcSEcCtD
Benzatropine—Confusional state—Epirubicin—breast cancer	0.000103	0.000953	CcSEcCtD
Benzatropine—Tachycardia—Epirubicin—breast cancer	0.0001	0.000923	CcSEcCtD
Benzatropine—Dry mouth—Doxorubicin—breast cancer	9.69e-05	0.000893	CcSEcCtD
Benzatropine—Vomiting—Docetaxel—breast cancer	9.67e-05	0.000891	CcSEcCtD
Benzatropine—Diphenhydramine—PTGS1—breast cancer	9.6e-05	0.0447	CrCbGaD
Benzatropine—Rash—Docetaxel—breast cancer	9.59e-05	0.000884	CcSEcCtD
Benzatropine—Dermatitis—Docetaxel—breast cancer	9.58e-05	0.000883	CcSEcCtD
Benzatropine—Confusional state—Doxorubicin—breast cancer	9.57e-05	0.000882	CcSEcCtD
Benzatropine—Decreased appetite—Methotrexate—breast cancer	9.53e-05	0.000878	CcSEcCtD
Benzatropine—Vomiting—Capecitabine—breast cancer	9.36e-05	0.000863	CcSEcCtD
Benzatropine—Rash—Capecitabine—breast cancer	9.29e-05	0.000856	CcSEcCtD
Benzatropine—Dermatitis—Capecitabine—breast cancer	9.28e-05	0.000855	CcSEcCtD
Benzatropine—Tachycardia—Doxorubicin—breast cancer	9.27e-05	0.000854	CcSEcCtD
Benzatropine—Cinnarizine—CYP2D6—breast cancer	9.1e-05	0.0424	CrCbGaD
Benzatropine—Nausea—Docetaxel—breast cancer	9.04e-05	0.000833	CcSEcCtD
Benzatropine—Feeling abnormal—Methotrexate—breast cancer	9.04e-05	0.000833	CcSEcCtD
Benzatropine—Decreased appetite—Epirubicin—breast cancer	8.92e-05	0.000822	CcSEcCtD
Benzatropine—Constipation—Epirubicin—breast cancer	8.77e-05	0.000809	CcSEcCtD
Benzatropine—Nausea—Capecitabine—breast cancer	8.75e-05	0.000806	CcSEcCtD
Benzatropine—Body temperature increased—Methotrexate—breast cancer	8.67e-05	0.000799	CcSEcCtD
Benzatropine—Feeling abnormal—Epirubicin—breast cancer	8.46e-05	0.000779	CcSEcCtD
Benzatropine—Decreased appetite—Doxorubicin—breast cancer	8.25e-05	0.000761	CcSEcCtD
Benzatropine—Constipation—Doxorubicin—breast cancer	8.12e-05	0.000748	CcSEcCtD
Benzatropine—Body temperature increased—Epirubicin—breast cancer	8.11e-05	0.000748	CcSEcCtD
Benzatropine—Atomoxetine—CYP2D6—breast cancer	8.09e-05	0.0377	CrCbGaD
Benzatropine—Hypersensitivity—Methotrexate—breast cancer	8.08e-05	0.000744	CcSEcCtD
Benzatropine—Modafinil—CYP3A4—breast cancer	8.07e-05	0.0376	CrCbGaD
Benzatropine—Fentanyl—CYP3A4—breast cancer	7.89e-05	0.0367	CrCbGaD
Benzatropine—Feeling abnormal—Doxorubicin—breast cancer	7.82e-05	0.000721	CcSEcCtD
Benzatropine—Hypersensitivity—Epirubicin—breast cancer	7.56e-05	0.000697	CcSEcCtD
Benzatropine—Body temperature increased—Doxorubicin—breast cancer	7.51e-05	0.000692	CcSEcCtD
Benzatropine—Benzphetamine—CYP3A4—breast cancer	7e-05	0.0326	CrCbGaD
Benzatropine—Hypersensitivity—Doxorubicin—breast cancer	6.99e-05	0.000645	CcSEcCtD
Benzatropine—Vomiting—Methotrexate—breast cancer	6.97e-05	0.000642	CcSEcCtD
Benzatropine—Atomoxetine—CYP3A4—breast cancer	6.94e-05	0.0323	CrCbGaD
Benzatropine—Rash—Methotrexate—breast cancer	6.91e-05	0.000637	CcSEcCtD
Benzatropine—Dermatitis—Methotrexate—breast cancer	6.91e-05	0.000637	CcSEcCtD
Benzatropine—Fentanyl—ABCB1—breast cancer	6.57e-05	0.0306	CrCbGaD
Benzatropine—Diphenhydramine—CYP2D6—breast cancer	6.54e-05	0.0304	CrCbGaD
Benzatropine—Vomiting—Epirubicin—breast cancer	6.52e-05	0.000601	CcSEcCtD
Benzatropine—Nausea—Methotrexate—breast cancer	6.51e-05	0.0006	CcSEcCtD
Benzatropine—Rash—Epirubicin—breast cancer	6.47e-05	0.000596	CcSEcCtD
Benzatropine—Dermatitis—Epirubicin—breast cancer	6.46e-05	0.000596	CcSEcCtD
Benzatropine—Nausea—Epirubicin—breast cancer	6.09e-05	0.000562	CcSEcCtD
Benzatropine—Vomiting—Doxorubicin—breast cancer	6.04e-05	0.000556	CcSEcCtD
Benzatropine—Rash—Doxorubicin—breast cancer	5.99e-05	0.000552	CcSEcCtD
Benzatropine—Dermatitis—Doxorubicin—breast cancer	5.98e-05	0.000551	CcSEcCtD
Benzatropine—Nausea—Doxorubicin—breast cancer	5.64e-05	0.00052	CcSEcCtD
Benzatropine—Orphenadrine—CYP3A4—breast cancer	5.3e-05	0.0247	CrCbGaD
Benzatropine—CYP2D6—Metabolism—NQO1—breast cancer	5.76e-06	9.86e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—SLC2A1—breast cancer	5.76e-06	9.86e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—SPP1—breast cancer	5.76e-06	9.86e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—CXCL8—breast cancer	5.75e-06	9.85e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—CXCL8—breast cancer	5.74e-06	9.81e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—NCOA1—breast cancer	5.73e-06	9.81e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—ERBB3—breast cancer	5.72e-06	9.78e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—FGFR2—breast cancer	5.71e-06	9.77e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—ERBB3—breast cancer	5.7e-06	9.75e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—FGFR2—breast cancer	5.69e-06	9.74e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—SPP1—breast cancer	5.69e-06	9.73e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—CXCL8—breast cancer	5.66e-06	9.69e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—STK11—breast cancer	5.65e-06	9.66e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CYP19A1—breast cancer	5.65e-06	9.66e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—ERBB3—breast cancer	5.63e-06	9.62e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CYP3A4—breast cancer	5.62e-06	9.62e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—FGFR2—breast cancer	5.62e-06	9.61e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CYP1B1—breast cancer	5.53e-06	9.45e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—IL2—breast cancer	5.5e-06	9.41e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—IL2—breast cancer	5.48e-06	9.38e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TERT—breast cancer	5.48e-06	9.38e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TERT—breast cancer	5.46e-06	9.35e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—HSP90AA1—breast cancer	5.42e-06	9.27e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—IL2—breast cancer	5.41e-06	9.26e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TERT—breast cancer	5.39e-06	9.22e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—FGFR1—breast cancer	5.32e-06	9.1e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—FGFR1—breast cancer	5.3e-06	9.07e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.3e-06	9.07e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—NCOA1—breast cancer	5.27e-06	9.02e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—COMT—breast cancer	5.25e-06	8.98e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—HIF1A—breast cancer	5.24e-06	8.97e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—FGFR1—breast cancer	5.24e-06	8.96e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GSTP1—breast cancer	5.23e-06	8.94e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—HIF1A—breast cancer	5.22e-06	8.94e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CYP19A1—breast cancer	5.2e-06	8.89e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—STK11—breast cancer	5.2e-06	8.89e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HIF1A—breast cancer	5.16e-06	8.82e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—HMOX1—breast cancer	5.15e-06	8.82e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ITPR1—breast cancer	5.14e-06	8.8e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—LEP—breast cancer	5.12e-06	8.75e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—LEP—breast cancer	5.1e-06	8.72e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CAV1—breast cancer	5.07e-06	8.67e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CAV1—breast cancer	5.05e-06	8.64e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—LEP—breast cancer	5.03e-06	8.61e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—KDR—breast cancer	5.01e-06	8.57e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—KDR—breast cancer	5e-06	8.55e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CAV1—breast cancer	4.99e-06	8.53e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ABCB1—breast cancer	4.95e-06	8.46e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—KDR—breast cancer	4.93e-06	8.44e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—ESR1—breast cancer	4.88e-06	8.36e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—ESR1—breast cancer	4.87e-06	8.33e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—TYMS—breast cancer	4.86e-06	8.31e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—COMT—breast cancer	4.83e-06	8.26e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—FN1—breast cancer	4.82e-06	8.25e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—FN1—breast cancer	4.81e-06	8.23e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GSTP1—breast cancer	4.81e-06	8.22e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—ESR1—breast cancer	4.81e-06	8.22e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PLA2G4A—breast cancer	4.8e-06	8.22e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—NCOR1—breast cancer	4.8e-06	8.22e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GSTM1—breast cancer	4.8e-06	8.22e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—NFKBIA—breast cancer	4.77e-06	8.16e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—NFKBIA—breast cancer	4.75e-06	8.13e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—FN1—breast cancer	4.75e-06	8.12e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—HMOX1—breast cancer	4.74e-06	8.11e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ITPR1—breast cancer	4.73e-06	8.09e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—NOTCH1—breast cancer	4.72e-06	8.08e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—NOTCH1—breast cancer	4.71e-06	8.05e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—NFKBIA—breast cancer	4.69e-06	8.03e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—NOTCH1—breast cancer	4.65e-06	7.95e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PIK3CG—breast cancer	4.62e-06	7.9e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—APC—breast cancer	4.62e-06	7.9e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—KIT—breast cancer	4.62e-06	7.9e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—KIT—breast cancer	4.6e-06	7.87e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PIK3CG—breast cancer	4.6e-06	7.87e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—APC—breast cancer	4.6e-06	7.87e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GPX1—breast cancer	4.6e-06	7.87e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—EGF—breast cancer	4.56e-06	7.81e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CYP1A1—breast cancer	4.55e-06	7.79e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ABCB1—breast cancer	4.55e-06	7.79e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—EGF—breast cancer	4.55e-06	7.78e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—KIT—breast cancer	4.54e-06	7.77e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—APC—breast cancer	4.54e-06	7.77e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PIK3CG—breast cancer	4.54e-06	7.77e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ERCC2—breast cancer	4.52e-06	7.73e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—EGF—breast cancer	4.49e-06	7.68e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—TYMS—breast cancer	4.47e-06	7.65e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—MAPK3—breast cancer	4.42e-06	7.56e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PLA2G4A—breast cancer	4.42e-06	7.56e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—NCOR1—breast cancer	4.42e-06	7.56e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GSTM1—breast cancer	4.42e-06	7.56e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—MAPK3—breast cancer	4.41e-06	7.54e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—MAPK3—breast cancer	4.35e-06	7.44e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—BRAF—breast cancer	4.34e-06	7.42e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—BRAF—breast cancer	4.33e-06	7.4e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—BRAF—breast cancer	4.27e-06	7.31e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—MTHFR—breast cancer	4.24e-06	7.26e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GPX1—breast cancer	4.23e-06	7.24e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IGF1—breast cancer	4.23e-06	7.23e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—AKT2—breast cancer	4.22e-06	7.23e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IGF1—breast cancer	4.21e-06	7.21e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—AKT2—breast cancer	4.21e-06	7.2e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—EGFR—breast cancer	4.21e-06	7.2e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—EGFR—breast cancer	4.19e-06	7.17e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CYP1A1—breast cancer	4.19e-06	7.17e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IGF1—breast cancer	4.16e-06	7.12e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—AKT2—breast cancer	4.16e-06	7.11e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ERCC2—breast cancer	4.15e-06	7.11e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—EGFR—breast cancer	4.14e-06	7.08e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PIK3CD—breast cancer	4.06e-06	6.94e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PIK3CD—breast cancer	4.05e-06	6.92e-05	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	4.02e-06	6.88e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—SERPINE1—breast cancer	4.01e-06	6.87e-05	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—PIK3CA—breast cancer	4.01e-06	6.86e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—SERPINE1—breast cancer	4e-06	6.85e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PIK3CD—breast cancer	3.99e-06	6.83e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—KRAS—breast cancer	3.97e-06	6.8e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—KRAS—breast cancer	3.96e-06	6.78e-05	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	3.96e-06	6.77e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—SERPINE1—breast cancer	3.95e-06	6.76e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CAV1—breast cancer	3.92e-06	6.7e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—KRAS—breast cancer	3.91e-06	6.69e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—MTHFR—breast cancer	3.9e-06	6.68e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—NOS3—breast cancer	3.83e-06	6.56e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—NOS3—breast cancer	3.82e-06	6.54e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—NOS3—breast cancer	3.77e-06	6.45e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.74e-06	6.4e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—PIK3CA—breast cancer	3.65e-06	6.25e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	3.64e-06	6.23e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MDM2—breast cancer	3.64e-06	6.22e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MDM2—breast cancer	3.62e-06	6.2e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—RAF1—breast cancer	3.62e-06	6.2e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—RAF1—breast cancer	3.61e-06	6.18e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—RELA—breast cancer	3.61e-06	6.17e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CAV1—breast cancer	3.6e-06	6.16e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—RELA—breast cancer	3.6e-06	6.15e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	3.59e-06	6.15e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—ERBB2—breast cancer	3.58e-06	6.13e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MDM2—breast cancer	3.58e-06	6.12e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—ERBB2—breast cancer	3.57e-06	6.11e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PIK3CG—breast cancer	3.57e-06	6.1e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—RAF1—breast cancer	3.57e-06	6.1e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—RELA—breast cancer	3.55e-06	6.07e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MTOR—breast cancer	3.54e-06	6.05e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PIK3CB—breast cancer	3.54e-06	6.05e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—ERBB2—breast cancer	3.53e-06	6.03e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MTOR—breast cancer	3.53e-06	6.03e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PIK3CB—breast cancer	3.53e-06	6.03e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MTOR—breast cancer	3.48e-06	5.96e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PIK3CB—breast cancer	3.48e-06	5.96e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CXCL8—breast cancer	3.4e-06	5.82e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CXCL8—breast cancer	3.39e-06	5.8e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—HRAS—breast cancer	3.38e-06	5.78e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—HRAS—breast cancer	3.37e-06	5.76e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CXCL8—breast cancer	3.35e-06	5.72e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—HRAS—breast cancer	3.32e-06	5.69e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CDKN1B—breast cancer	3.32e-06	5.68e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CDKN1B—breast cancer	3.31e-06	5.66e-05	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—AKT1—breast cancer	3.28e-06	5.62e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PIK3CG—breast cancer	3.28e-06	5.61e-05	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—AKT1—breast cancer	3.27e-06	5.6e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CDKN1B—breast cancer	3.27e-06	5.59e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CASP3—breast cancer	3.25e-06	5.57e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IL2—breast cancer	3.25e-06	5.56e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CASP3—breast cancer	3.24e-06	5.55e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IL2—breast cancer	3.24e-06	5.54e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—IL6—breast cancer	3.23e-06	5.53e-05	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—AKT1—breast cancer	3.23e-06	5.53e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—IL6—breast cancer	3.22e-06	5.51e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CASP3—breast cancer	3.2e-06	5.48e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IL2—breast cancer	3.2e-06	5.47e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—IL6—breast cancer	3.18e-06	5.44e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CCND1—breast cancer	3.17e-06	5.42e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—JUN—breast cancer	3.16e-06	5.41e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CCND1—breast cancer	3.16e-06	5.4e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—JUN—breast cancer	3.15e-06	5.39e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CTNNB1—breast cancer	3.14e-06	5.37e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PIK3CD—breast cancer	3.14e-06	5.36e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CTNNB1—breast cancer	3.13e-06	5.35e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CCND1—breast cancer	3.12e-06	5.33e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—JUN—breast cancer	3.11e-06	5.32e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ALB—breast cancer	3.1e-06	5.3e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CTNNB1—breast cancer	3.09e-06	5.28e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MMP9—breast cancer	3.07e-06	5.26e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MMP9—breast cancer	3.07e-06	5.24e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CDKN1A—breast cancer	3.06e-06	5.24e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PTEN—breast cancer	3.06e-06	5.23e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CDKN1A—breast cancer	3.05e-06	5.23e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PTEN—breast cancer	3.05e-06	5.21e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MMP9—breast cancer	3.03e-06	5.18e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CDKN1A—breast cancer	3.01e-06	5.16e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PTEN—breast cancer	3.01e-06	5.15e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MAPK8—breast cancer	2.99e-06	5.12e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—AKT1—breast cancer	2.98e-06	5.1e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MAPK8—breast cancer	2.98e-06	5.1e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—AKT1—breast cancer	2.97e-06	5.09e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—NOS3—breast cancer	2.96e-06	5.07e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MAPK8—breast cancer	2.94e-06	5.03e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—AKT1—breast cancer	2.93e-06	5.02e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PIK3CD—breast cancer	2.88e-06	4.93e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ALB—breast cancer	2.85e-06	4.87e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—SRC—breast cancer	2.83e-06	4.85e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—SRC—breast cancer	2.83e-06	4.83e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—SRC—breast cancer	2.79e-06	4.77e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—VEGFA—breast cancer	2.76e-06	4.72e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—VEGFA—breast cancer	2.75e-06	4.71e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—STAT3—breast cancer	2.73e-06	4.68e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PIK3CB—breast cancer	2.73e-06	4.68e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—STAT3—breast cancer	2.73e-06	4.66e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—NOS3—breast cancer	2.72e-06	4.66e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—VEGFA—breast cancer	2.72e-06	4.65e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PTGS2—breast cancer	2.71e-06	4.63e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—STAT3—breast cancer	2.69e-06	4.6e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MAPK3—breast cancer	2.61e-06	4.47e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MAPK3—breast cancer	2.6e-06	4.45e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MAPK3—breast cancer	2.57e-06	4.4e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MYC—breast cancer	2.54e-06	4.35e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TGFB1—breast cancer	2.53e-06	4.34e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MYC—breast cancer	2.53e-06	4.33e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TGFB1—breast cancer	2.53e-06	4.32e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PIK3CB—breast cancer	2.51e-06	4.3e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MYC—breast cancer	2.5e-06	4.28e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TGFB1—breast cancer	2.49e-06	4.27e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PTGS2—breast cancer	2.49e-06	4.26e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—EGFR—breast cancer	2.48e-06	4.25e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—EGFR—breast cancer	2.48e-06	4.24e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—EGFR—breast cancer	2.44e-06	4.18e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PTEN—breast cancer	2.36e-06	4.04e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—KRAS—breast cancer	2.35e-06	4.02e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—KRAS—breast cancer	2.34e-06	4e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—KRAS—breast cancer	2.31e-06	3.95e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PTEN—breast cancer	2.17e-06	3.72e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PIK3CA—breast cancer	2.16e-06	3.69e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PIK3CA—breast cancer	2.15e-06	3.68e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	2.12e-06	3.63e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TP53—breast cancer	2.09e-06	3.57e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TP53—breast cancer	2.08e-06	3.56e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TP53—breast cancer	2.05e-06	3.51e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—HRAS—breast cancer	2e-06	3.41e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—HRAS—breast cancer	1.99e-06	3.4e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HRAS—breast cancer	1.96e-06	3.36e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IL6—breast cancer	1.91e-06	3.27e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IL6—breast cancer	1.9e-06	3.26e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IL6—breast cancer	1.88e-06	3.21e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—AKT1—breast cancer	1.76e-06	3.01e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—AKT1—breast cancer	1.76e-06	3e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—AKT1—breast cancer	1.73e-06	2.97e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PIK3CA—breast cancer	1.67e-06	2.85e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.53e-06	2.62e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—AKT1—breast cancer	1.36e-06	2.33e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—AKT1—breast cancer	1.25e-06	2.14e-05	CbGpPWpGaD
